MedTrace Logo

A Study of Real-world Treatment Patterns and Outcomes in Chinese Advanced NSCLC Patients Who Previously Received at Least 2 Line Treatments

NCT06617390 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1041

Last updated 2025-08-03

No results posted yet for this study

Summary

This study will retrospectively collect data of patients with advanced non-small cell lung cancer who have received at least 2 line treatment to investigate treatment patterns, relevant outcomes, and biomarkers detection patterns in Chinese patients with Actionable Genomic Alterations (AGA) or non-AGA.

Conditions

  • Non-small Cell Lung Cancer (NSCLC)

Interventions

OTHER

No drug

This is a non-interventional study and no study drug will be provided.

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-08-15
Primary Completion
2025-01-26
Completion
2025-07-30

Countries

  • China

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06617390 on ClinicalTrials.gov